Sort by
Refine Your Search
-
, computer scientists, data scientists, and data engineers to define and implement community standards for knowledge representation and interchange. The successful applicant will conduct novel research in
-
electronics. New materials are continually being developed for electronic applications, and accurate measurements of the electromagnetic properties of these often complex new materials is critical both
-
such as dynamic nuclear polarization which allow for enhanced signals useable to track metabolite conversion in the body are of interest. NIST is also working on low-field spectroscopy and ultra-low field
-
. The NIST channel sounding measurement team specializes in the development and use of instrumentation in the 10s of GHz based on phased array antennas that is optimized to capture dynamically evolving
-
that allow ceramics to be densified at thermal budgets considerably lower than used in traditional sintering, which typically requires temperatures above 1000 °C. One prominent example is ceramic cold
-
the carbon dioxide system in seawater using methods such as total alkalinity, total dissolved inorganic carbon, and spectrophotometric pH, (2) evaluation of synthetic solutions to measure ion fitting
-
, health care, and nuclear security applications. No instrument today directly measures all decays in a sample with sufficient energy resolution to uniquely identify each radionuclide. NIST is developing a 4
-
consolidation of precursor metal materials into metal 3D parts and structures, enabling complex geometry and material designs. The fundamental physics of these processes is relatively complex, involving various
-
Nuclear Magnetic Resonance (NMR) and Magnetic Resonance Imaging (MRI) are key techniques used in the biological and medical fields, there is a growing use of these technologies in industrial settings
-
analytical methods that are rapid, reliable, and sensitive. We are developing model cell expression systems based on rodent (Chinese Hamster Ovary Cells) that produce monoclonal antibodies at high levels